Lockheed Martin Stock: The +444% EPS Beat Is a MIRAGE — Why LMT Is Still a BUY (Q2 2026)

Lockheed Martin (LMT) Q2 2026 — Lockheed Martin (LMT), the world's largest pure-play defense prime (F-35, PAC-3/THAAD missile defense, Sikorsky, Space), reported a headline-grabbing Q2 2026: GAAP diluted EPS of $7.94 beat the ~$7.22 estimate (+444% YoY) on revenue of $20.1B (+11%), with free cash flow of $2.9B (vs -$150M a year ago) and every segment profitable. But the +444% is mostly optics — it laps ~$1.6B (~$5/sh) of 2025 program charges; underlying EPS grew ~20%. The real story: a RECORD $230B backlog (~2.9x sales) and a missile-defense supercycle — Missiles & Fire Control grew +19% (14.5% margin), and a $35B THAAD award nearly doubled that segment's backlog to ~$88B. Management RAISED full-year 2026 guidance across the board (sales $79.8-81.8B, EPS $29.95-30.65, FCF $7.0-7.2B). The stock popped ~6% to ~$543, still ~21% below its $692 high. Our owner-earnings DCF (normalized ~$7.0B FCF; base-defense vs Golden Dome paths; 8-10% discount) lands fair value ~$585 — modestly above the price. Our call: BUY, 3/5. Lockheed Martin (LMT) is the world's largest pure-play defense contractor — the F-35 stealth fighter, PAC-3 and THAAD missile interceptors, Sikorsky Black Hawk helicopters, and national-security satellites. Q2 2026 looked like a blowout: GAAP diluted EPS of $7.94 crushed the ~$7.22 estimate (+444% YoY), revenue rose 11% to $20.1B, free cash flow swung to $2.9B (from -$150M a year ago), every segment was profitable, and management RAISED full-year 2026 guidance across the board (sales $79.8-81.8B, EPS $29.95-30.65, FCF $7.0-7.2B). But the +444% headline is mostly an illusion: it laps ~$1.6B (~$5/share) of one-time 2025 program charges — strip those out and underlying EPS grew a still-solid ~20%. The genuinely important story is durability: a RECORD $230B backlog (~2.9x annual sales), and a missile-defense supercycle showing up in hard numbers — Missiles & Fire Control grew +19% with a 14.5% margin, and a $35B THAAD award nearly doubled that segment's backlog to ~$88B ('Golden Dome' / munitions replenishment). The catch is real: Lockheed is a serial charge-taker on fixed-price programs, buybacks are paused ($0 in H1 vs $1.25B a year ago), and F-35 deliveries collapsed to 19 (from 50). Our owner-earnings DCF — normalizing the flattered ~$8.7B TTM cash to ~$7.0B, weighting a base-defense path (+4%) more than an optimistic Golden Dome path (+7%), at an 8-10% discount — lands fair value near $585, modestly above the ~$543 price. Our call: BUY, 3/5 — reasonable value on a record backlog, a blue-chip fortress finally on sale, tempered by the charge history and the paused buyback. We're constructive but more conservative than the Street's ~$623 average target (Buy, 21 of 37 analysts). Own it for the backlog, add on weakness toward the low $500s, and mind the charge risk. Not financial advice. THE CALL: BUY (3/5, REASONABLE VALUE ON A RECORD BACKLOG — A BEAT-AND-RAISE WHERE THE +444% HEADLINE HIDES THE REAL STORY) — base-case value ~$585 vs ~$543 today. What to watch: two or three clean, charge-free quarters in a row, the F-35 delivery pace normalizing, and continued Golden Dome / munitions orders flooding the backlog would prove execution has genuinely turned and move us from a 3 to a 4; the risk to respect is another surprise reach-forward charge on a fixed-price program (Lockheed's recurring Achilles' heel) or missile-defense budget momentum stalling, either of which could turn today's reasonable multiple back into a value trap Also on YouTube: @ChargedAlpha DISCLAIMER: For informational and educational purposes only. Not financial advice. Do your own research before any investment decision.